移植临床医生对估算肾小球滤过率中使用种族的意见
该调查于2020年12月至2021年2月对美国成人肾移植中心工作人员进行,评估其对基于种族的eGFR方程用于等待名单和活体供者评估的意见。结果显示仅6%受访者认为当前方程适当,多数担忧消除种族可能带来危害,且超过三分之一中心缺乏胱抑素C或实测GFR检测。
要点
- 仅6%受访者认为当前基于种族的eGFR计算器适当。
- 79%受访者担忧消除种族可能带来危害。
- 超过三分之一中心缺乏胱抑素C或实测GFR检测。
核心结论
- 普遍共识是现有GFR估算方法不令人满意,但意见存在差异。
研究设计与样本
- 对美国成人肾移植中心工作人员进行问卷调查,应答代表57%(124/218)的移植项目。
主要发现
- 93%项目使用基于血清肌酐的eGFR进行候选者登记。
- 仅6%受访者认为当前基于种族的eGFR计算器适当。
- 70%受访者认为消除种族将允许更多黑人患者抢先登记。
- 79%受访者担忧消除种族可能带来危害。
- 40%中心不计划移除种族,46%计划移除,15%已移除。
关键数值与推荐
- 黑人与非黑人活体供者的GFR接受阈值无差异。
临床怎么用
- 临床医生应了解当前eGFR方程的局限性,并关注种族移除对移植公平性的影响。
局限性
- 调查仅代表57%的成人肾移植项目,应答存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Current race-based eGFR calculators assign a higher eGFR value to Black patients, which could affect the care of kidney transplant candidates and potential living donors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a survey of staff at adult kidney transplant centers in the United States (December 17, 2020 to February 28, 2021) to assess opinions on use of race-based eGFR equations for waitlisting and living donor candidate evaluation, availability of serum cystatin C testing and measured GFR, and related practices. RESULTS: Respondents represented 57% (124 of 218) of adult kidney transplant programs, and the responding centers conducted 70% of recent kidney transplant volume. Most (93%) programs use serum creatinine-based eGFR for listing candidates. However, only 6% of respondents felt that current race-based eGFR calculators are appropriate, with desire for change grounded in concerns for promotion of health care disparities by current equations and inaccuracies in reporting of race. Most respondents (70%) believed that elimination of race would allow more preemptive waitlisting for Black patients, but a majority (79%) also raised concerns that such an approach could incur harms. More than one third of the responding programs lacked or were unsure of availability of testing for cystatin C or measured GFR. At this time, 40% of represented centers did not plan to remove race from eGFR calculators, 46% were planning to remove, and 15% had already done so. There was substantial variability in eGFR reporting and listing of multiracial patients with some Black ancestry. There was no difference in GFR acceptance thresholds for Black versus non-Black living donors. CONCLUSIONS: This national survey highlights a broad consensus that extant approaches to GFR estimation are unsatisfactory, but it also identified a range of current opinions.
引用
- Doshi MD, Singh N, Hippen BE, et al. Transplant Clinician Opinions on Use of Race in the Estimation of Glomerular Filtration Rate. Clin J Am Soc Nephrol. 2021. PMID: 34620650. doi:10.2215/CJN.05490421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。